Goldman Sachs Maintains Sell on 10x Genomics, Lowers Price Target to $25
Goldman Sachs analyst Matthew Sykes maintains 10x Genomics (NASDAQ:TXG) with a Sell and lowers the price target from $35 to $25.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
Gainers
Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.